Gene · 442906
Papers1,644
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,644
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LncRNA SNHG1: role in tumorigenesis of multiple human cancers. | Cancer Cell Int | 2023 | 37684619 | PubTator, text mining | PubMed |
| Mechanism of miRNA-31 Regulating Wnt/β-catenin Signaling Pathway by Targeting Satb2 in the Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells. | J Musculoskelet Neuronal Interact | 2023 | 37654220 | PubTator, text mining | PubMed |
| MiRNA-related metastasis in oral cancer: moving and shaking. | Cancer Cell Int | 2023 | 37635248 | PubTator, text mining | PubMed |
| MicroRNA-338-3p helps regulate ovarian function by affecting granulosa cell function and early follicular development. | J Ovarian Res | 2023 | 37633947 | PubTator, text mining | PubMed |
| EIF4A3-mediated circ_0042881 activates the RAS pathway via miR-217/SOS1 axis to facilitate breast cancer progression. | Cell Death Dis | 2023 | 37626035 | PubTator, text mining | PubMed |
| Mechanism of lncRNA FOXD3-AS1/miR-338-3p in the malignant progression of nasopharyngeal carcinoma through ceRNA. | Cell Mol Biol (Noisy-le-grand) | 2023 | 37605586 | PubTator, text mining | PubMed |
| Advances in the study of exosomes derived from mesenchymal stem cells and cardiac cells for the treatment of myocardial infarction. | Cell Commun Signal | 2023 | 37580705 | PubTator, text mining | PubMed |
| Tectorigenin: A Review of Its Sources, Pharmacology, Toxicity, and Pharmacokinetics. | Molecules | 2023 | 37570873 | PubTator, text mining | PubMed |
| Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene Therapy. | Cells | 2023 | 37566027 | PubTator, text mining | PubMed |
| Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma. | Mol Cancer | 2023 | 37488598 | PubTator, text mining | PubMed |
| The recent progress of endocrine therapy-induced osteoporosis in estrogen-positive breast cancer therapy. | Front Oncol | 2023 | 37483519 | PubTator, text mining | PubMed |
| Identification of autophagy-associated circRNAs in sepsis-induced cardiomyopathy of mice. | Sci Rep | 2023 | 37479790 | PubTator, text mining | PubMed |
| circRPS19 affects HK2‑mediated aerobic glycolysis and cell viability via the miR‑125a‑5p/USP7 pathway in gastric cancer. | Int J Oncol | 2023 | 37449524 | PubTator, text mining | PubMed |
| Cerebrospinal Fluid Biomarkers for Diagnosis and the Prognostication of Acute Ischemic Stroke: A Systematic Review. | Int J Mol Sci | 2023 | 37446092 | PubTator, text mining | PubMed |
| A comprehensive insight into the correlation between ncRNAs and the Wnt/β-catenin signalling pathway in gastric cancer pathogenesis. | Cell Commun Signal | 2023 | 37386429 | PubTator, text mining | PubMed |
| Insights into the Role of Plasmatic and Exosomal microRNAs in Oxidative Stress-Related Metabolic Diseases. | Antioxidants (Basel) | 2023 | 37372020 | PubTator, text mining | PubMed |
| Integrating Multi-Omics Analysis for Enhanced Diagnosis and Treatment of Glioblastoma: A Comprehensive Data-Driven Approach. | Cancers (Basel) | 2023 | 37370767 | PubTator, text mining | PubMed |
| Diagnostic and prognostic role of circRNAs in pancreatic cancer: a meta-analysis. | Front Oncol | 2023 | 37361594 | PubTator, text mining | PubMed |
| Circular RNA circBNC2 facilitates glycolysis and stemness of hepatocellular carcinoma through the miR-217/high mobility group AT-hook 2 (HMGA2) axis. | Heliyon | 2023 | 37360090 | PubTator, text mining | PubMed |
| Circulating and Endometrial Tissue microRNA Markers Associated with Endometrial Cancer Diagnosis, Prognosis, and Response to Treatment. | Cancers (Basel) | 2023 | 37345024 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/442906/papers?page=4